More articles from MTA I: Radiopharmaceutical Therapy Posters

You have access
Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer
Wolfgang Fendler, Harun Ilhan, Philipp Paprottka, Peter Bartenstein, Marcus Hacker and Alexander Haug

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1386;
You have access
Efficacy of peptide receptor radionuclide therapy as first or second line treatment in metastatic pulmonary neuroendocrine neoplasms
Manal Sayeg, Harshad Kulkarni, Dieter Hörsch and Richard Baum

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1382;
You have access
Biodegradable drug delivery system for hepatoma therapy
Tsai-Yueh Luo, Liang-Yu Chang, Ping-Fang Chiang and Wuu-Jyh Lin

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1391;
You have access
Radiation dosimetry in 177Lu-DOTATATE therapy - Inter and intra patient variability
Adam Kesner, Yodphat Krausz, Martine Klein and Nanette Freedman

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1376;
You have access
Preparation and stability of radiolabeling human serum albumin (HSA) microspheres with 188Re(I)-tricarbonyl technology
Chiayu Yu, Su-Jung Chen, Chien-Hong Lin, Liang-Cheng Chen, Chih-Hsien Chang and Te-Wei Lee

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1390;
You have access
Whether PRRT connecting with long acting somatostatin analogue may lengthen survival in group of patients with NET?
Anna Sowa-Staszczak, Renata Mikolajczak, Monika Tomaszuk and Alicja Hubalewska-Dydejczyk

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1381;
You have access
A comparative study of 89Sr, bisphosphonates and 89Sr plus bisphosphonates therapy of bone metastases: A systematic review
Jia Guo and Anren Kuang

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1404;
You have access
Evaluation of melanin-targeted radiotherapy in combination with radiosensitizers in a spheroid model
Sharon Hutchison, Colin Rae, John Babich and Robert Mairs

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1402;
You have access
Impact of peptide receptor radionuclide therapy (PRRT) on the 68Ga-DOTATOC-PET/CT uptake in normal tissue
Frederik Giesel, Mesla Stefanova, Ali Afshar-Oromieh, Walter Mier, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1378;
You have access
Methodology for radiobiological optimization of combination radiopharmaceutical therapy (RPT)
Robert Hobbs, Richard Wahl, Eric Frey, Hong Song, Yvette Kasamon, Peng Huang, Richard Jones and George Sgouros

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1401;

Main menu

User menu

Search

More articles from MTA I: Radiopharmaceutical Therapy Posters

Pages